OncoImmune
A clinical-stage biopharmaceutical company engaging in drug discovery and drug development for treating autoimmune disease and cancer.
5
Funding Rounds
$76.5m
Money raised
Overview
A clinical-stage biopharmaceutical company engaging in drug discovery and drug development for treating autoimmune disease and cancer.
- Website:
- Business model: B2B
- Social accounts: linkedin
Funding
Funding series
Funding Series Analysis
The company OncoImmune has raised a total of $20.5m in funding over 5 rounds.
Key Insights:
- OncoImmune, Inc. funding round, April 2020: $1.5m
- OncoImmune Grant (money), July 2018: $2m
- OncoImmune Grant (money), September 2017: $2m
- OncoImmune Series A round, January 2017: $15m
- OncoImmune Series B round September 2020: $56m
OncoImmune, Inc. funding round, April 2020
$1.5m
OncoImmune Grant (money), July 2018
$2m
OncoImmune Grant (money), September 2017
$2m
OncoImmune Series A round, January 2017
$15m
OncoImmune Series B round September 2020
$56m
Industries
OncoImmune is active in the following industries: